Product Detail

loading

Share to:
facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
sharethis sharing button

Cas No. 56616-91-2, 3-Bromo-1-methyl-1H-1,2,4-triazole

  • 56616-91-2

  • C3H4BrN3

  • 161.99

  • 1.93±0.1

  • Psoriasis

  • Deucravacitinib

  • 11/7/2033 (Deucravacitinib)

  • tyrosine kinase 2

Availability:

DESCRIPTION

Deucravacitinib, a selective tyrosine kinase 2 inhibitor, presents a new frontier in the management of autoimmune diseases, including psoriasis, ulcerative colitis, and Crohn's disease. Our high-quality intermediates ensure a reliable supply of Deucravacitinib, supported by a seamless and optimized production process. Join forces with us to bring this game-changing treatment to patients worldwide, transforming the landscape of autoimmune disease management. Explore the possibilities with Deucravacitinib and make a difference in healthcare.

Previous: 
Next: